10.17037/DATA.00003106
Lawrence, David
David
Lawrence
https://orcid.org/0000-0002-5439-4039
London School of Hygiene & Tropical Medicine
Ssali, Agnes
Agnes
Ssali
https://orcid.org/0000-0003-4801-0411
London School of Hygiene & Tropical Medicine
Moshashane, Neo
Neo
Moshashane
Nabaggala, Georgina
Georgina
Nabaggala
London School of Hygiene & Tropical Medicine
Maphane, Lebogang
Lebogang
Maphane
Harrison, Thomas
Thomas
Harrison
Meya, David
David
Meya
London School of Hygiene & Tropical Medicine
Jarvis, Joseph
Joseph
Jarvis
https://orcid.org/0000-0003-1459-5554
London School of Hygiene & Tropical Medicine
Seeley, Janet
Janet
Seeley
https://orcid.org/0000-0002-0583-5272
London School of Hygiene & Tropical Medicine
Support files for: The acceptability of the AMBITION-cm treatment regimen for HIV-associated cryptococcal meningitis: findings from a qualitative methods study of participants and researchers in Botswana and Uganda
London School of Hygiene & Tropical Medicine
2022
Interview guides
2022
Creative Commons Attribution 4.0 International
The AMBITION-cm trial for HIV-associated cryptococcal meningitis had a qualitative methods study embedded within the AMBITION-cm sites in Botswana and Uganda. Eligible trial participants, surrogate decision makers, and researchers at both sites were contacted to participate in a set of in-depth interviews (IDIs). This fileset contains a set of collection tools produced and used for the in-depth interviews, as well as the participation information sheets, consent forms and interview schedules for each group.
We embedded a qualitative methods study within the AMBITION-cm sites in Botswana and Uganda. Interviews were conducted and combined with direct observations. Consecutively eligible trial participants were approached to participate in two in-depth interviews (IDIs). The first IDI took place at least six weeks into the ten-week trial and the other at least four weeks after the final trial appointment. Secondly, consecutively eligible surrogate decision makers were approached to participate in a single in-depth interview at least six weeks after having provided consent for a trial participant. Finally, we interviewed researchers working on the AMBITION-cm trial on a single occasion. Altogether, we interviewed 38 trial participants, 20 surrogate decision makers, and 31 researchers. Interviews were transcribed, translated, and analysed thematically.